133 related articles for article (PubMed ID: 2423813)
1. Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus.
Layer P; Rizza RA; Zinsmeister AR; Carlson GL; DiMagno EP
Mayo Clin Proc; 1986 Jun; 61(6):442-7. PubMed ID: 2423813
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal and metabolic effects of amylase inhibition in diabetics.
Boivin M; Flourie B; Rizza RA; Go VL; DiMagno EP
Gastroenterology; 1988 Feb; 94(2):387-94. PubMed ID: 2446948
[TBL] [Abstract][Full Text] [Related]
3. Impairment of starch absorption by a potent amylase inhibitor.
Brugge WR; Rosenfeld MS
Am J Gastroenterol; 1987 Aug; 82(8):718-22. PubMed ID: 2440298
[TBL] [Abstract][Full Text] [Related]
4. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans.
Layer P; Zinsmeister AR; DiMagno EP
Gastroenterology; 1986 Jul; 91(1):41-8. PubMed ID: 2423408
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus.
Layer P; Go VL; DiMagno EP
Gut; 1989 Sep; 30(9):1279-84. PubMed ID: 2478426
[TBL] [Abstract][Full Text] [Related]
6. Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans.
Layer P; Carlson GL; DiMagno EP
Gastroenterology; 1985 Jun; 88(6):1895-902. PubMed ID: 2581844
[TBL] [Abstract][Full Text] [Related]
7. Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans.
Boivin M; Zinsmeister AR; Go VL; DiMagno EP
Mayo Clin Proc; 1987 Apr; 62(4):249-55. PubMed ID: 2436011
[TBL] [Abstract][Full Text] [Related]
8. A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man.
Carlson GL; Li BU; Bass P; Olsen WA
Science; 1983 Jan; 219(4583):393-5. PubMed ID: 6184780
[TBL] [Abstract][Full Text] [Related]
9. Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies.
Hollenbeck CB; Coulston AM; Quan R; Becker TR; Vreman HJ; Stevenson DK; Reaven GM
Am J Clin Nutr; 1983 Oct; 38(4):498-503. PubMed ID: 6414283
[TBL] [Abstract][Full Text] [Related]
10. Starch blockers--their effect on calorie absorption from a high-starch meal.
Bo-Linn GW; Santa Ana CA; Morawski SG; Fordtran JS
N Engl J Med; 1982 Dec; 307(23):1413-6. PubMed ID: 6182469
[TBL] [Abstract][Full Text] [Related]
11. Effect of a wheat amylase inhibitor on canine carbohydrate digestion, gastrointestinal function, and pancreatic growth.
Koike D; Yamadera K; DiMagno EP
Gastroenterology; 1995 Apr; 108(4):1221-9. PubMed ID: 7535274
[TBL] [Abstract][Full Text] [Related]
12. Postprandial carbohydrate metabolism in healthy subjects and those with type 2 diabetes fed starches with slow and rapid hydrolysis rates determined in vitro.
Seal CJ; Daly ME; Thomas LC; Bal W; Birkett AM; Jeffcoat R; Mathers JC
Br J Nutr; 2003 Nov; 90(5):853-64. PubMed ID: 14667179
[TBL] [Abstract][Full Text] [Related]
13. Intestinal transport and fermentation of resistant starch evaluated by the hydrogen breath test.
Olesen M; Rumessen JJ; Gudmand-Høyer E
Eur J Clin Nutr; 1994 Oct; 48(10):692-701. PubMed ID: 7835324
[TBL] [Abstract][Full Text] [Related]
14. Pasta cooking time: influence on starch digestion and plasma glucose and insulin responses in healthy subjects.
Bornet FR; Cloarec D; Barry JL; Colonna P; Gouilloud S; Laval JD; Galmiche JP
Am J Clin Nutr; 1990 Mar; 51(3):421-7. PubMed ID: 2178390
[TBL] [Abstract][Full Text] [Related]
15. Chestnut astringent skin extract, an alpha-amylase inhibitor, retards carbohydrate absorption in rats and humans.
Tsujita T; Takaku T; Suzuki T
J Nutr Sci Vitaminol (Tokyo); 2008 Feb; 54(1):82-8. PubMed ID: 18388412
[TBL] [Abstract][Full Text] [Related]
16. Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice.
Murai A; Iwamura K; Takada M; Ogawa K; Usui T; Okumura J
Life Sci; 2002 Aug; 71(12):1405-15. PubMed ID: 12127161
[TBL] [Abstract][Full Text] [Related]
17. Slowly digested and absorbed carbohydrate in traditional bushfoods: a protective factor against diabetes?
Thorburn AW; Brand JC; Truswell AS
Am J Clin Nutr; 1987 Jan; 45(1):98-106. PubMed ID: 3541565
[TBL] [Abstract][Full Text] [Related]
18. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro.
Gin H; Rigalleau V; Caubet O; Masquelier J; Aubertin J
Metabolism; 1999 Sep; 48(9):1179-83. PubMed ID: 10484061
[TBL] [Abstract][Full Text] [Related]
19. Effect of trestatin, an amylase inhibitor, incorporated into bread, on glycemic responses in normal and diabetic patients.
Golay A; Schneider H; Temler E; Felber JP
Am J Clin Nutr; 1991 Jan; 53(1):61-5. PubMed ID: 1701612
[TBL] [Abstract][Full Text] [Related]
20. Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese, and diabetic humans.
Lankisch M; Layer P; Rizza RA; DiMagno EP
Pancreas; 1998 Aug; 17(2):176-81. PubMed ID: 9700950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
